Tramadol Contraindications
Tramadol is contraindicated in patients with previous hypersensitivity to tramadol, any component of the product, or opioids, and in situations where opioids are contraindicated, including acute intoxication with alcohol, hypnotics, narcotics, centrally acting analgesics, opioids, or psychotropic drugs. 1
Absolute Contraindications
- Hypersensitivity to tramadol, any component of the product, or opioids 1
- Acute intoxication with alcohol, hypnotics, narcotics, centrally acting analgesics, opioids, or psychotropic drugs 1
- Concomitant use of MAO inhibitors or use within 14 days of MAO inhibitor treatment (risk of potentially fatal interactions) 1
- Children younger than 12 years (FDA contraindication) 2
- Children younger than 18 years who are undergoing tonsillectomy and/or adenoidectomy (FDA contraindication) 2
Relative Contraindications and Cautions
Neurological Concerns
- History of seizures or risk factors for seizures 1, 3
- Concomitant use of medications that lower seizure threshold, including:
- Risk of serotonin syndrome with concomitant use of:
Respiratory Concerns
- Respiratory depression risk (use with caution in at-risk patients) 1
- Patients with increased intracranial pressure or head trauma 1
- Adolescents aged 12-18 years who are obese or have conditions that increase risk of serious breathing problems (e.g., obstructive sleep apnea, severe lung disease) 2
- Concomitant use with CNS depressants (use reduced dosages) 1, 4
Hepatic and Renal Concerns
Other Cautions
- Patients with suicidal tendencies or addiction-prone individuals 1
- Patients with emotional disturbance or depression 1
- Patients taking tranquilizers or antidepressant drugs 1
- Patients who use alcohol in excess 1
- Patients with liver cirrhosis (bioavailability may increase 2-3 fold; limit to 50mg every 12 hours) 2
Special Populations
Pediatric Population
- FDA guidelines contraindicate tramadol for:
Elderly Population
- Higher risk for adverse effects from CNS depressants and tramadol combinations 4
- May require dose adjustment due to age-related changes in metabolism 4
Monitoring and Management
- Monitor for signs of respiratory depression, excessive sedation, and serotonin syndrome in patients on tramadol 4
- Educate patients about signs of respiratory depression, excessive sedation, and serotonin syndrome 4
- Use lowest effective dose when tramadol cannot be avoided in high-risk patients 4
- Consider non-opioid analgesics (acetaminophen, NSAIDs) as alternatives for pain management when appropriate 4
Tramadol in Specific Conditions
- Fibromyalgia: Tramadol has shown efficacy but carries risk of side effects and potential for abuse; careful monitoring required 2
- Hepatocellular carcinoma with liver cirrhosis: Limited to 50mg within 12 hours due to increased bioavailability 2
- Patients with seizure disorders: High risk of exacerbating seizures; alternative analgesics preferred 1, 3
Tramadol's unique mechanism as both a weak opioid agonist and a serotonin-norepinephrine reuptake inhibitor contributes to its efficacy but also to its distinct adverse effect profile and contraindications 3, 5. Understanding these contraindications is essential for safe prescribing practices.